inavolisib: Clinical Trials

1 trial of inavolisib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow inavolisib: new trials by email Literature Review of inavolisib trials Research Report on inavolisib

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer
Capecitabine, Talazoparib, Pembrolizumab - Breast Cancer, Triple Negative Breast Cancer
Phase 2TerminatedBryan Schneider, MD522021-08-242025-05-31

Conditions studied

Breast Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Bryan Schneider, MD (1)

Countries

United States (1)

Top investigators

Bryan P Schneider, MD (1)